Report
Kodiak Sciences stock surged 125% after late-stage drug trial success
Forbes reports that the trial tested two experimental eye drugs, Zenkuda and tabirafusp-ted, for wet age-related macular degeneration.
TLDR
Forbes reports that Kodiak Sciences stock surged 125% after a successful late-stage drug trial. The trial tested two experimental eye drugs, Zenkuda and tabirafusp-ted, for wet age-related macular degeneration.
Combined views
51.5K
2 Sources, first seen ago
